Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial (116622)

ARTG ID

116622

ARTG Name

MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

May 10, 2006

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sanofi-Aventis Australia Pty Ltd

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/89d5cfa69b8d16afa7fe11280524a9d0.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ce0addbe386ea0433428d421e338a8e8.pdf

Active Ingredients

Ingredient Name

Alemtuzumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy